On this page

Meeting

COT Meeting: 2nd February 2021

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 2nd February 2021 via Microsoft Teams

Last updated: 06 July 2021

View as PDF

On this page

Meeting Agenda

  1. Apologies for absence
  2. Draft minutes of December meeting TOX/MIN/2021/01
  3. Matters arising
  4. Additional information requested by the Committee on allergenicity of chitin and chitosan based BBFCMs  TOX/2021/03
  5. Second draft statement on potential risks from mycotoxins   TOX/2021/04
  6. Prioritisation of dietary components and xenobiotics for future papers on their effects on maternal health – Part1        TOX/2021/05
  7. PBPK for Regulators Workshop Report: First draft (Reserved) TOX/2021/06
  8. Variable life time exposure and first draft statement. TOX/2021/07
  9. Discussion paper on the potential effects that excess vitamin D intake may have during preconception, pregnancy and lactation. TOX/2021/08
  10. Draft EFSA Scientific Committee Opinion on biological plausibility of non monotonic dose responses and their impact on the risk assessment. TOX/2021/09
  11. COT annual report  TOX/2021/10
  12. Horizon scanning TOX/2021/11
  13. Update on actions taken subsequent to COT advice - for information TOX/2021/12
  14. Update on the work of other advisory committees- for information TOX/2021/13
  15. Any other business

Next meeting of the Committee at 10.00am on Tuesday 23rd March 2021 via TEAMs.

Proposed list of BBFCMs for health risk assessment  TOX/2021/01

  • Additional data on MYTOX research group TOX/2021/02
  • Update on JEGs 

Media discussed during the meeting

Please see information on reserved items on the Procedure for holding COT meetings in open session page

TOX MIN 2021 - 01

Draft minutes of the meeting of the Committee at 10:00 held on the 1st December 2020 via Microsoft Teams

TOX 2021 - 01

Proposed list of bio-based food contact materials (BBFCMs) for health risk assessment

TOX 2021 - 02

Additional data on Mycotoxin and Toxigenic Moulds (MYTOX) research group

TOX 2021 - 03

Additional information requested by the Committee on allergenicity of chitin and chitosan based bio-based food contact materials (BBFCMs)

TOX 2021 - 04

Second draft statement on potential risks from mycotoxins

TOX 2021 - 05

Prioritisation of dietary components and xenobiotics for future papers on their effects on maternal health – Part 1

TOX 2021 - 06

PBPK for Regulators Workshop Report: First draft
(Reserved)

TOX 2021 - 07

Variable life time exposure and first draft statement

TOX 2021 - 08

Discussion paper on the potential effects that excess vitamin D intake may have during preconception, pregnancy and lactation

TOX 2021 - 09

Draft EFSA Scientific Committee Opinion on biological plausibility of non monotonic dose responses and their impact on the risk assessment

TOX 2021 - 10

Draft COT annual report (2020)

Annex A of TOX 2021 - 10 

TOX 2021 - 11

Horizon scanning

TOX 2021 - 12

Update on actions taken subsequent to COT advice - for information

TOX 2021 - 13

Update on the work of other advisory committees - for information

*PDF coming soon*

TOX 2020 - 63-65

Item 10 minutes: EU exit update on regulated products (reserved)

COT Meeting : 2nd February 2021 Agenda

Meeting of the Committee at 10:00, Tuesday 2nd February 2021 via Microsoft Teams

Final minutes of the meeting of the Committee on 2nd February 2021

The final minutes of the meeting of the Committee held on Tuesday 2nd February 2021 via Microsoft Teams